NCT06397677
Defining the Molecular and Radiologic Phenotype of Progressive RA Interstitial Lung Disease
Recruiting · Not specified · University of Colorado, Denver · registry updated 2024-05-03
Inclusion and exclusion lines below are quoted from ClinicalTrials.gov. No match score is shown, because a score needs a person's age, biomarkers, and treatment dates. Confirm the record with the study team.
A study to identify patients with Rheumatoid Arthritis - Associated Interstitial Lung Disease (RA-ILD) that are at the highest risk for progression. The goal of the investigators is to recruit a group of patients with RA-ILD and collect information to help us understand more about disease progression. The investigators will do this using a combination of clinical, radiologic, and biologic features.
Inclusion
- Multidisciplinary diagnosis of RA-ILD based on the 2010 American College of Rheumatology criteria
- years of age or older
Exclusion
- Prior medication treatment specifically for RA-ILD
- Inability to give informed consent
- Pregnant women